Top Markets
#1 DogBull DogBull +53.26%
#2 OriginTrail OriginTrail +16.86%
#3 龙虾 (Lobster) 龙虾 (Lobster) +10.64%
#4 Siren Siren +10.53%
#5 Verus Coin Verus Coin +8.62%
#6 COTI COTI +7.40%
#7 Tutorial Tutorial +7.07%
#8 Stargate Finance Stargate Finance +7.05%
#9 PulseChain PulseChain +6.89%
#10 Yield Basis Yield Basis +6.63%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Classifica tra le azioni #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Prezzo delle azioni
$0.3479
Ultima sincronizzazione: 2024-08-21
Capitalizzazione di mercato
$94.92M
Variazione (1 giorno)
0.64%
Variazione (1 anno)
0.00%
Paese
US
Scambia Asensus Surgical, Inc. (ASXC)

Categoria

Healthcare
Ricavi di Asensus Surgical, Inc. (ASXC)
Ricavi nel Jun 2024 TTM: $9.85M
Secondo gli ultimi rapporti finanziari di Asensus Surgical, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $9.85M. Nel 2022, l'azienda ha registrato ricavi di $7.09M una diminuzione rispetto a i ricavi dell'anno 2021, che erano pari a $8.23M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Asensus Surgical, Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $9.85M 14.84%
2023 $8.58M 21.02%
2022 $7.09M -13.91%
2021 $8.23M 159.28%
2020 $3.18M -62.78%
2019 $8.53M -64.60%
2018 $24.10M 238.94%
2017 $7.11M 368.14%
2016 $1.52M 0.00%
2015 0.00 -100.00%
2014 $401.00K -71.98%
2013 $1.43M -32.34%
2012 $2.12M 0.00%
2011 0.00 -100.00%
2010 $-29.00 0.00%
2009 0.00 0.00%
2008 0.00 -100.00%
2007 $-135.00K 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 $231.00K -98.04%
2002 $11.77M -42.34%
2001 $20.42M -21.40%
2000 $25.97M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 472,844.16%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 262,204.57%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 360,143.65%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 213,057.36%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE